Surmodics (STU:SU6) FCF Margin % : 19.23% (As of Mar. 2024)

View and export this data going back to 2018. Start your Free Trial

What is Surmodics FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Surmodics's Free Cash Flow for the three months ended in Mar. 2024 was €5.7 Mil. Surmodics's Revenue for the three months ended in Mar. 2024 was €29.4 Mil. Therefore, Surmodics's FCF Margin % for the quarter that ended in Mar. 2024 was 19.23%.

As of today, Surmodics's current FCF Yield % is 3.77%.

The historical rank and industry rank for Surmodics's FCF Margin % or its related term are showing as below:

STU:SU6' s FCF Margin % Range Over the Past 10 Years
Min: -20.6 Med: 10.66 Max: 27.69
Current: 15.8

During the past 13 years, the highest FCF Margin % of Surmodics was 27.69%. The lowest was -20.60%. And the median was 10.66%.

STU:SU6's FCF Margin % is ranked better than
89.94% of 825 companies
in the Medical Devices & Instruments industry
Industry Median: -7.06 vs STU:SU6: 15.80

Surmodics FCF Margin % Historical Data

The historical data trend for Surmodics's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Surmodics FCF Margin % Chart

Surmodics Annual Data

Trend

Sep14

Sep15

Sep16

Sep17

Sep18

Sep19

Sep20

Sep21

Sep22

Sep23

FCF Margin %

Get a 7-Day Free Trial

1.29

10.90

8.67

-20.60

5.73

Surmodics Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
FCF Margin %	Get a 7-Day Free Trial															-24.08	48.44	1.79	-31.13	19.23

Competitive Comparison of Surmodics's FCF Margin %

For the Medical Devices subindustry, Surmodics's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Surmodics's FCF Margin % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Surmodics's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Surmodics's FCF Margin % falls into.

Surmodics FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Surmodics's FCF Margin for the fiscal year that ended in Sep. 2023 is calculated as

FCF Margin	=	Free Cash Flow (A: Sep. 2023 )	/	Revenue (A: Sep. 2023 )
	=	7.118	/	124.231
	=	5.73 %

Surmodics's FCF Margin for the quarter that ended in Mar. 2024 is calculated as

FCF Margin	=	Free Cash Flow (Q: Mar. 2024 )	/	Revenue (Q: Mar. 2024 )
	=	5.653	/	29.401
	=	19.23 %

Surmodics FCF Margin % Related Terms

Thank you for viewing the detailed overview of Surmodics's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Surmodics (STU:SU6) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Surmodics Inc (STU:SU6) » Definitions » FCF Margin %

Comparable Companies

Traded in Other Exchanges

SRDX:USA SU6:Germany

Address

9924 West 74th Street, Eden Prairie, MN, USA, 55344

Website

https://www.surmodics.com

Surmodics Inc is a provider of surface modification and in vitro diagnostic technologies to the healthcare industry. The company's mission is to improve the treatment and detection of disease by using its technology to provide solutions to difficult medical devices and diagnostic challenges. It has two reportable segments: Medical device unit; Manufacture of performance coatings, including surface modification coating technologies and the Vitro diagnostics unit; Manufacture of chemical and biological components used in in vitro diagnostic immunoassay and molecular tests within the diagnostic and biomedical research markets. Surmodics derives majority of its revenue from the Medical Device segment.

Surmodics (STU:SU6) Headlines

No Headlines